Active Specific Immunotherapy (ASI) And Gcmaf Forte In Management Of Metastatic Invasive Carcinoma

Active Specific Immunotherapy (ASI) And Gcmaf Forte In Management Of Metastatic Invasive Carcinoma

by

Dr. Roni Moya, Prof. Dr. Mike K.S. Chan, Dr. Dmytro Klokol and Dr. Patricia Pan

Journal of Clinical & Experimental Immunology; 3(2), 2018
https://www.opastpublishers.com/open-access-articles/active-specific-immunotherapy-asi-and-gcmaf-forte-in-management-of-metastatic-invasive-carcinomaoverview-of-the-therapeu.pdf